Betamax Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.28 Cr
as on 23-10-2024
- Paid Up Capital ₹ 2.27 Cr
as on 23-10-2024
- Company Age 28 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.10 Cr
as on 23-10-2024
- Satisfied Charges ₹ 1.18 Cr
as on 23-10-2024
About Betamax Remedies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.28 Cr and a paid-up capital of Rs 2.27 Cr.
The company currently has active open charges totaling ₹1.10 Cr. The company has closed loans amounting to ₹1.18 Cr, as per Ministry of Corporate Affairs (MCA) records.
Parminderjit Toor and Sunil Singh serve as directors at the Company.
- CIN/LLPIN
U24239CH1996PTC018058
- Company No.
018058
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Apr 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Betamax Remedies Private Limited offer?
Betamax Remedies Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Brain & Nervous System Drugs, Antiepileptic Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops.
Who are the key members and board of directors at Betamax Remedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parminderjit Toor  | Managing Director | 16-Oct-2006 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Singh | Additional Director | 18-May-2023 | Current |
Financial Performance of Betamax Remedies.
Betamax Remedies Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Betamax Remedies?
In 2023, Betamax Remedies had a public holding of 29.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 24 Dec 2018 | ₹7.43 M | Open |
Director Of Industries Creation Date: 01 Jul 2009 | ₹3.00 M | Open |
Punjab National Bank Creation Date: 18 Sep 1996 | ₹0.30 M | Open |
How Many Employees Work at Betamax Remedies?
Betamax Remedies has a workforce of 35 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Betamax Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Betamax Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
